Brief: Roche Receives FDA 510(K) Clearance For Cobas® C703 And Cobas® Ise Neo
30/03/2026 14:41
March 30 (Reuters) - Roche Holding AG ROPC.S: ROCHE: RECEIVES FDA 510(K) CLEARANCE FOR COBAS® C703 AND COBAS® ISE NEO Source text: ID:nPn8wZtlWa Further company coverage: ROPC.S ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Roche Holding AG
See all newsTable: Swiss trade surplus at CHF 6.11 bln in May
Brief: Roche - FDA Accepts Supplemental Biologics License Application For Lunsumio And Polivy Combination
Swiss stocks - Factors to watch on June 18
FDA approves first generic version of Roche's flu drug
Brief: FDA Approves First Single-Dose Generic Treatment For Influenza